Fig. 6From: Suicide gene therapy using allogeneic adipose tissue-derived mesenchymal stem cell gene delivery vehicles in recurrent glioblastoma multiforme: a first-in-human, dose-escalation, phase I clinical trialKaplan-Meier curve for both overall survival (OS) (A) and progression-free survival (PFS) (B) in all patients and those with unmethylated MGMT promoter undergoing suicide gene therapyBack to article page